
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
Think all your good counsel to parents on the criticality of immunizations can win over caregivers vacillating on vaccinations?
Think all your good counsel to parents on the criticality of immunizations can win over caregivers vacillating on vaccinations? Hear one of the authors of a






